Top of this page
Skip navigation, go straight to the content
Thanks to our teams’ proactive and agile approach to executing our plans, 2010 will be remembered as a year of a strong, collective performance.
This achievement was underpinned by robust “management by objective” processes, including UCB’s vision, strategy, roadmap and individual objectives. After a period of intense reorganisation, UCB is now firmly on the path of becoming a much leaner biopharma, with new skills, knowledge and competencies.